Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rutgers The State University of New Jersey - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013176
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the areas of accounting and information systems, aerospace engineering, Africana studies, agricultural and resource management agents, agricultural, food, and resource economics, environmental sciences, epidemiology, and others. Rutgers operates through its campuses in New Brunswick, Newark, and Camden. The university provides services, solutions, and clinical care for individuals and the local, national, and global communities. Rutgers is headquartered in New Brunswick, New Jersey, the US.

Rutgers The State University of New Jersey – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Licensing Agreements 16
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey – Key Competitors 24
Rutgers The State University of New Jersey – Key Employees 25
Rutgers The State University of New Jersey – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Strategy And Business Planning 28
Feb 29, 2016: Z53 Therapeutics, A New Oncology Start-Up, Launches to Combat Cancer-Associated Mutation 28
Government and Public Interest 29
Feb 17, 2016: Cancer Study is ‘Paradigm Shift’ in Cause of Tumor Formation 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Key Facts 2
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey, Key Competitors 24
Rutgers The State University of New Jersey, Key Employees 25
Rutgers The State University of New Jersey, Other Locations 26
Rutgers The State University of New Jersey, Subsidiaries 26
Rutgers The State University of New Jersey, Joint Venture 27

★海外企業調査レポート[Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Largan Precision Co Ltd (3008):企業の財務・戦略的SWOT分析
    Largan Precision Co Ltd (3008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Israel Chemicals Ltd.:企業のM&A・事業提携・投資動向
    Israel Chemicals Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Israel Chemicals Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • Banner Health:企業の戦略的SWOT分析
    Banner Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Guardant Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Centerchem Inc:企業の戦略・SWOT・財務情報
    Centerchem Inc - Strategy, SWOT and Corporate Finance Report Summary Centerchem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nationwide Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • SPAR Osterreichische Warenhandels AG:企業の戦略的SWOT分析
    SPAR Osterreichische Warenhandels AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Siemens Healthineers.:企業のM&A・事業提携・投資動向
    Siemens Healthineers. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Healthineers. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • GEN energija, d.o.o.:発電所・企業SWOT分析
    GEN energija, d.o.o. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Sime Darby Unimills B.V. :企業の戦略・SWOT・財務情報
    Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates:企業の戦略・SWOT・財務情報
    Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report Summary Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Mitsui & Co., Ltd.:企業のM&A・事業提携・投資動向
    Mitsui & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsui & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • MiaSole Hi-Tech Corp:電力:M&Aディール及び事業提携情報
    Summary MiaSole Hi-Tech Corp (MiaSole) is an alternative energy company that manufactures, designs, develops, and markets thin-film photovoltaic solar cells and panels. The company's products include flexible solar cells, custom modules and SolarRide. It offers photovoltaic products for large-scale …
  • Highland Gold Mining Limited
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Taylor Wessing Llp:企業の戦略・SWOT・財務分析
    Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing Llp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kyocera Corporation (6971):企業の財務・戦略的SWOT分析
    Kyocera Corporation (6971) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Gale Pacific Ltd (GAP):企業の財務・戦略的SWOT分析
    Gale Pacific Ltd (GAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆